Quantum Genomics: the first line against high blood pressure and heart failure (Flash Matin / Obs – french only)
HTA: firibastat, leader of a new therapeutic class (Egora.fr – french only)
Patient-Based Culture (PharmaVoice)
Tulane working on new stroke drugs that tweak brain chemistry (The New Orleans Advocate)
Aminopeptidase A inhibitor shows promise for BP lowering in high-risk patients (Healio)
Podcast : New Treatment for Resistant Hypertension with JP Milon Quantum Genomics (Empowered Patient)
Podcast : A Hearts and Minds Strategy for Cardiovascular Disease (Bio Report)
Hypertension: a new therapeutic target for patients who are difficult to treat (Why Doctor – French only)
Jean-Philippe Milon, CEO of Quantum Genomics: “It makes it easier for us to sign a partnership tomorrow” – Interview conducted on the Web TV www.laboursetlavie.com (French only)
Firibastat looking good for difficult-to-treat hypertension (MDedge)